lyme disease glutathione Antioxidant Treatment for For chronic inflammation, especially from
Description
This does not mean injectable GHK-Cu is ineffective in humans -- it means the evidence does not yet exist to confirm or quantify its effects
Additionally, overexpression of ZDHHC11 did not elevate S-palmitoylation levels in ATG2A with C-terminal cysteine substitutions at C1704, C1713, and C1714, indicating that these residues are the target sites for ZDHHC11 (Figs
PMID: 57 YamadaNKarasawaTItoJYamamuroDMorimotoKNakamuraTet al
Luo et al., 2019
